Monday, April 15, 2024

People from Canada and Russia are raising concerns about the decision to change the rankings of the figure skating team event at the 2022 Winter Olympics. They are making official requests to reconsider the decision

Must read

- Advertisement -
- Advertisement -

There’s an ongoing issue with the figure skating team event results at the 2022 Winter Olympics. Canada and Russia have brought their cases to the Court of Arbitration for Sport (CAS).

CAS shared that there are several appeals about how the International Skating Union (ISU) changed the team event results in Beijing. This happened after they removed Kamila Valieva’s scores because she got a drug ban last month. Now, Canada wants to move up from fourth to bronze, and Russia wants their ROC team to go back to the gold medal position after dropping to bronze.

Back in 2022, during the Olympics, the ROC won gold, the US got silver, and Japan got bronze in an event. But things got complicated when it turned out that Valieva, a 15-year-old athlete, tested positive for a heart medication called trimetazidine. This drug can improve endurance.

The positive test happened during the Russian national championships before the Winter Olympics. Fast forward almost two years, on January 29, CAS (Court of Arbitration for Sport) said Valieva couldn’t compete for four years due to breaking anti-doping rules. The ban started on December 25, 2021.

On January 30, the ISU (International Skating Union) changed the order of teams in the event because of Valieva’s disqualification. Now, the US, Japan, and ROC got the Olympic medals in that order, dropping the ROC from gold to bronze. Canada stayed in fourth place, just one point behind the ROC.

Canada disagrees with how the ISU rearranged the teams and thinks it should be ahead of the ROC. The ISU insists they followed the rules correctly. CAS mentioned on Monday that arbitration procedures for appeals from Russia and Canada just began. They didn’t say when a possible hearing might happen.

- Advertisement -
- Advertisement -

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest article